Discover 2,010 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,010
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: New Haven CT, Quebec, New York NY, New Brunswick NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase3, Recruiting
Clinician Satisfaction With the VERABAND™
for
Chronic Low-back Pain
Location: Ann Arbor MI, Kansas City KS
Sponsor: University of Michigan
Sex: All
Age: 18 - 70+
Code: NCT06080464
Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
for
Acute Decompensated Heart Failure
Location: Stony Brook NY, Philadelphia PA, Richmond VA,
Sponsor: Reprieve Cardiovascular, Inc
Sex: All
Age: 22+
Code: NCT06898515
Phase3, Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
for
Somatostatin Receptor Positive (SSTR+),
Location: Hartford CT, New Haven CT, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06784752
Phase3, Recruiting
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
for
Lymphoma, Lymphoma, Non Hodgkin
Location: New York NY, Philadelphia PA, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07082803
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
for
Cancer, Cancer Survivors, Gastrointestinal Cancers,
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 18+
Code: NCT06908629
Recruiting
First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy
for
Non Small Cell Lung Cancer
Location: Detroit MI
Sponsor: Nerissa T. Viola
Sex: All
Age: 18+
Code: NCT06439914
Phase1, Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT06941272
Phase1, Phase2, Recruiting
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Boston MA, Quebec, The Bronx NY, Albany NY, Montreal,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase2, Phase3, Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
for
Staphylococcus Aureus
Location: Ridgewood NY, Jersey City NJ, Bethlehem PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 55
Code: NCT06749457
Phase1, Phase2, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Boston MA, Wilson NC, Chapel Hill NC, Pembroke Pines FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase1, Phase2, Recruiting
Featured
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
for
Hepatocellular Carcinoma
Location: Roanoke VA, Detroit MI, Louisville KY, Chicago IL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06109272
Phase2, Phase3, Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Philadelphia PA, Coral Springs FL, Tampa FL,
Sponsor: Prelude Therapeutics
Sex: All
Age: 18+
Code: NCT07469891
Phase1, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase3, Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
for
Carcinoid Syndrome, Carcinoid, Carcinoid Tumor,
Location: New Haven CT, New York NY, Philadelphia PA,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT07087054
Phase3, Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
for
Acute Promyelocytic Leukemia (APL),
Location: The Bronx NY, Baltimore MD, Charlottesville VA,
Sponsor: Quetzal Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07504458
Phase3, Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
for
Primary Membranous Nephropathy
Location: The Bronx NY, Greenville NC, London, Cleveland OH,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT06962800
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Sarasota FL, Detroit MI,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06682988
Phase2, Recruiting
FITting Non-invasive Tests in Lynch Syndrome Surveillance